Browsing Tag
sebetralstat
1 post
KalVista Pharmaceuticals wins EU and Swiss approval for EKTERLY—what does this mean for the stock?
KalVista Pharmaceuticals secures EU and Swiss approval for EKTERLY, the first oral HAE therapy. Can this rare disease breakthrough lift KALV stock?